School of Medicine, University of Toronto, Toronto, Ontario, Canada.
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Medicine (Baltimore). 2024 Aug 2;103(31):e39109. doi: 10.1097/MD.0000000000039109.
The diagnosis, etiology, and optimal management of fibromyalgia remains contentious. This uncertainty may result in variability in clinical management. We conducted a systematic review and meta-analysis of cross-sectional studies examining physicians' knowledge, attitudes, and practices regarding fibromyalgia.
We searched MEDLINE, Embase, and PubMed from inception to February 2023 for cross-sectional surveys evaluating physicians' attitudes toward, and management of, fibromyalgia. Pairs of independent reviewers conducted article screening, data extraction, and risk of bias assessment in duplicate. We used random-effects meta-analysis to pool proportions for items reported by more than one study and the Grading of Recommendations Assessment, Development, and Evaluation approach to summarize the certainty of evidence.
Of 864 citations, 21 studies (8904 participants) were eligible for review. Most physicians endorsed fibromyalgia as a distinct clinical entity (84%; 95% confidence interval [CI], 74-92), and half (51%; 95% CI, 40-62) considered fibromyalgia a psychosocial condition. Knowledge of formal diagnostic criteria for fibromyalgia was more likely among rheumatologists (69%, 95% CI, 45-89) versus general practitioners (38%, 95% CI, 24-54) (P = .04). Symptom relief was endorsed as the primary management goal by most physicians (73%, 95% CI, 52-90). Exercise, physiotherapy, antidepressants, nonsteroidal anti-inflammatory drugs, and non-opioid analgesics were most endorsed for management of fibromyalgia, but with wide variability between surveys. Opioids and most complementary and alternative interventions (e.g., homeopathy, chiropractic, and massage) received limited endorsement.
There is moderate certainty evidence to suggest that physicians are divided regarding whether fibromyalgia is a biomedical or psychosocial disorder. Physicians typically prioritize symptom relief as the primary goal of management, and often endorse management with exercise, non-opioid analgesics, nonsteroidal anti-inflammatory drugs, antidepressants, and physiotherapy (moderate to high certainty evidence); however, important practice variation exists.
纤维肌痛的诊断、病因和最佳治疗仍存在争议。这种不确定性可能导致临床管理的差异。我们对横断面研究进行了系统评价和荟萃分析,以检查医生对纤维肌痛的知识、态度和实践。
我们从 2023 年 2 月开始在 MEDLINE、Embase 和 PubMed 中搜索评估医生对纤维肌痛的态度和管理的横断面调查。两名独立审查员重复进行文章筛选、数据提取和偏倚风险评估。我们使用随机效应荟萃分析汇总超过一项研究报告的项目的比例,并使用推荐评估、制定和评估方法总结证据的确定性。
在 864 条引文中有 21 项研究(8904 名参与者)符合审查条件。大多数医生认为纤维肌痛是一种独特的临床实体(84%;95%置信区间[CI],74-92),一半(51%;95%CI,40-62)认为纤维肌痛是一种心理社会状况。风湿病学家(69%,95%CI,45-89)比全科医生(38%,95%CI,24-54)更了解纤维肌痛的正式诊断标准(P=0.04)。大多数医生(73%,95%CI,52-90)将症状缓解作为主要管理目标。运动、物理治疗、抗抑郁药、非甾体抗炎药和非阿片类镇痛药是治疗纤维肌痛最常被认可的药物,但各调查之间存在很大差异。阿片类药物和大多数补充和替代干预措施(例如顺势疗法、整脊和按摩)的认可程度有限。
有中等确定性证据表明,医生对于纤维肌痛是一种生物医学还是心理社会障碍存在分歧。医生通常将症状缓解作为管理的主要目标,并且通常会选择运动、非阿片类镇痛药、非甾体抗炎药、抗抑郁药和物理治疗来管理(中等至高确定性证据);然而,实践存在重要差异。